ストックスクリーナーアプリを入手
5.25
2.34%
0.12
前日終値:
$5.13
開ける：
$5.14
24時間の取引高:
103.55K
Relative Volume:
0.87
時価総額：
$106.64M
収益：
当期純損益:
$-33.63M
株価収益率:
-2.7452
EPS:
-1.9124
ネットキャッシュフロー:
$-47.63M
1週間 パフォーマンス:
+11.23%
1か月 パフォーマンス:
-0.38%
6か月 パフォーマンス:
+13.15%
1年 パフォーマンス:
+52.62%
1日の値動き範囲:
$5.11
$5.25
1週間の範囲:
$4.77
$5.25
52週間の値動き範囲:
$3.14
$5.73
Polypid Ltd Stock (PYPD) Company Profile
Compare PYPD vs VRTX, REGN, MRNA, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
5.25 | 106.64M | 0 | -33.63M | -47.63M | -1.9124 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-05 | 開始されました | Roth Capital | Buy |
| 2025-06-02 | 再開されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2021-09-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-07-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-24 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | 開始されました | Alliance Global Partners | Buy |
| 2020-07-21 | 開始されました | BMO Capital Markets | Outperform |
| 2020-07-21 | 開始されました | Barclays | Overweight |
| 2020-07-21 | 開始されました | Raymond James | Outperform |
すべてを表示
Polypid Ltd (PYPD) 最新ニュース
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026 - GlobeNewswire Inc.
PolyPid Ltd.Ordinary Shares (Nasdaq:PYPD) Stock Quote - The Chronicle-Journal
PYPD Q2 2026 Earnings: PolyPid Posts Narrower-Than-Expected Loss With No Reported RevenueFinancial Data - dars.gov.et
PolyPid (PYPD): Will The November FDA Decision Propel The Stock? - RTTNews
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - vinanet.vn
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - dars.gov.et
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - dars.gov.et
PolyPid (PYPD) Stock: Finishes 0.59% Up at $5.13 in the Current Update; Trading Range - www.dars.gov.et
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction: Shares Close 1.40% Higher in Latest TradingRetail Earnings Report - vinanet.vn
PolyPid | 3: Initial statement of beneficial ownership of securities- Warshavsky Ori - Moomoo
PolyPid | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] - Moomoo
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction - dars.gov.et
PolyPid (PYPD) Q2 2026 Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Closing Reaction: Shares Close 1.40% Higher in Latest TradingEarnings Season Preview - dars.gov.et
AIGH Capital Management LLC Purchases Shares of 1,504,741 PolyPid Ltd. $PYPD - MarketBeat
PolyPid Ltd (PYPD) Stock News Today - TradingKey
PolyPid Ltd. (PYPD) Holds Near $4.75 as Clinical-Stage Biotech Navigates Key Support ZoneCall Resistance - vinanet.vn
Conferencia de resultados del 2T de 2026 de PolyPid (PYPD): revisión prioritaria de D-PLEX100 y acuerdo con Azurity - TradingKey
What is HC Wainwright's Forecast for PolyPid Q3 Earnings? - MarketBeat
PolyPid (PYPD) Earnings Call zum 2. Quartal 2026: Prioritäre Prüfung für D-PLEX100 und Azurity-Deal - TradingKey
PolyPid Ltd. (PYPD) Holds Near $4.75 as Clinical-Stage Biotech Navigates Key Support ZoneRisk Reversal - dars.gov.et
LanzaTech Global Warrant (LNZAW) Holds Steady at $0.02 as Support and Resistance ConvergeExtension Target - dars.gov.et
Roth MKM Maintains PolyPid(PYPD.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
PolyPid (PYPD) investors disclose up to 13.4% beneficial stake via complex structure - Stock Titan
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneBollinger Walk - dars.gov.et
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWyckoff Distribution - vinanet.vn
HC Wainwright Issues Negative Estimate for PolyPid Earnings - MarketBeat
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWedge Breakout - dars.gov.et
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneGEX Level - careplusvn.com
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneDaily Profile - https://www.dars.gov.et/
PolyPid Ltd. (PYPD) Slips 2.27% to $4.73 as Shares Test Key Support ZoneWedge Breakout - dars.gov.et
PolyPid Earnings Call: Priority Review, Big Azurity Deal - TipRanks
PolyPid Ltd (PYPD) (Q2 2026) Earnings Call Highlights: FDA Priority Review and $30M Azurity ... - Yahoo Finance
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline - TipRanks
PolyPid Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
PolyPid (PYPD) secures $30M Azurity payments but flags going concern risk - Stock Titan
Transcript : PolyPid Ltd., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
Rosalind entities (PYPD) report 9.9% PolyPid stake, with 4.56M warrant shares blocked at 9.99% - Stock Titan
PolyPid Releases Q2 2026 Financial Results - AlphaStreet
PolyPid (NASDAQ:PYPD) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
PolyPid Q2 Earnings Call Highlights - NewsBreak: Local News & Alerts
PolyPid Q2 Earnings Call Highlights - MarketBeat
PolyPid Q2 Earnings Call Highlights - MarketBeat
PolyPid Q2 Earnings Call Highlights - TradingView
PolyPid Q2 losses narrow 55%, FDA accepts D-PLEX100 NDA - scanx.trade
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com Australia
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com India
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com Canada
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com
PolyPid Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: PolyPid narrows loss in Q2 2026 as stock falls premarket - Investing.com
Polypid Ltd (PYPD) 財務データ
収益
当期純利益
現金流量
EPS
3.09%
0.72%
大文字化:
|
ボリューム (24 時間):